Get 20% Discount on Botulinum Neurotoxins: a Comparative Industry Analysis of Products, Pipelines, Technologies and Stakeholders (Valid Upto 31 Dec 2014)

Submitted by: Submitted by

Views: 63

Words: 553

Pages: 3

Category: Science and Technology

Date Submitted: 11/26/2014 01:26 AM

Report This Essay

Nov, 26th, 2014, Mumbai, India: Bharat Book Bureau presents the report, on “Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders”. The significance of recombinant DNA technology is discussed regarding botulinum neurotoxin engineering, modification and manufacturing. Chances and challenges for the stakeholders in the botulinum neurotoxin market are evaluated.

Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders

This business report from July 2014 is based on the identification, description and assessment of all relevant stakeholders in the field of botulinum neurotoxins. The report analyzes the existing product portfolios in regulated and less regulated markets, commercial information, and measures to maintain sales and market shares by upside indications and life cycle management measures. The report addresses the new wave of botulinum neurotoxin product candidates in development, such as biosimilars and biosuperior botulinum neurotoxins.

Special emphasis is put in the report on improvements by pharmaceutical technologies, such as liquid protein formulations and transdermal drug delivery technologies. The significance of recombinant DNA technology is discussed regarding botulinum neurotoxin engineering, modification and manufacturing. Chances and challenges for the stakeholders in the botulinum neurotoxin market are evaluated.

The market for botulinum neurotoxin products has significantly grown over the last years, due to new medical indications developed and due to more cosmetic procedures performed with botulinum neurotoxins in ageing societies in which physical appearance is highly valued. Although the botulinum neurotoxin market commercially is dominated by only one company, existing competitors, new players and technologies are setting the ground for biosuperiors as well as for biosimilars. As biosimilar botulinum toxins will put the price...